[Principles of the effect of cytostatics].
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001215:Asparaginase / Q000627:therapeutic use; D002455:Cell Division / Q000187:drug effects; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000627:therapeutic use; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D008558:Melphalan / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy; D014228:Triaziquone / Q000627:therapeutic use; D013721:Triethylenephosphoramide / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D003561:Cytarabine; D002699:Chlorambucil; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001215:Asparaginase; D014228:Triaziquone; D013721:Triethylenephosphoramide; D008558:Melphalan; D005472:Fluorouracil; D008727:Methotrexate
Prinzipien der Wirkung von Zytostatika